EMBRYONIC DEVELOPMENT & STEM CELL COMPENDIUM
Content
All Cell Therapies > Cell Therapy Card
Sign in for full access

ICEF15, autologous myoblasts for fecal incontinence

ICEF15 is comprised of autologous myoblasts collected from the upper arm for the treatment of fecal incontinence. The patient’s ex vivo-expanded muscle cells are re-injected into the patient’s external anal sphincter muscle, using Innovacell’s proprietary injection device, leading to regeneration of the muscle´s full functionality. Treatment induced a rapid and sustained reduction in the symptoms of fecal incontinence, as well as an improvement in the quality of life.

Clinical trial 2010-021463-32 phase 2.
ICEF15, autologous myoblasts for fecal incontinence